Huntington’s Disease in Hospitalized Patients Infected with SARS-CoV-2 in Brazil: Three-Year Update
Patients with HD can be considered an at-risk population due to the poor clinical outcomes compared to patients without comorbidities. Even then, this group of patients presented fewer clinical signs and comorbidities.
Authors
- Fernando Augusto Lima Marson (ORCID: https://orcid.org/0000-0003-4955-4234)
- Juliana Mozer Sciani (ORCID: https://orcid.org/0000-0001-7213-206X)
- Jéssica Paula Martins (ORCID: https://orcid.org/0000-0002-4180-756X)
Institutions
- Laboratory of Molecular Genetics (PL)
- Universidade São Francisco (BR)
Publication Details
- Journal
- Neurodegenerative Diseases
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1159/000538170
- Citations
- 1
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.91
Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico